Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 3:42 PM
Ignite Modification Date:
2025-12-24 @ 3:42 PM
NCT ID:
NCT00483392
Eligibility Criteria:
Inclusion Criteria:
* documented HIV infection
* stable Protease Inhibitor containing HAART regimen for at least 12 months
* impaired glucose tolerance
* elevated insulin levels (above 20 mIU/l)
Exclusion Criteria:
* patients already taking oral hypoglycaemic treatment or insulin
* heart failure NYHA I-IV
* liver disease or kidney disease
* elevated AST or ALT above 2 times upper normal range
* elevated creatinine (above 150 mmol/l)
Sex:
MALE
Minimum Age:
18 Years
Maximum Age:
60 Years
Study:
NCT00483392
Study Brief:
Protocol Section:
NCT00483392